HCPLive® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.
Diagnosis and Treatment of Immune-Mediated Kidney Diseases
March 9th 2023In this program, renal experts will discuss management of immune-mediated kidney diseases. They will discuss challenges in diagnosis of immunoglobulin A neuropathy (IgAN) and C3 glomerulopathy (C3G) and emerging treatment options for them.
Personalizing Treatment Selection in Atopic Dermatitis
December 20th 2022Expert dermatologists discuss 3 patient case scenarios and their approach to finding the best treatment for each patient type. They discuss data, pros and cons of use of various classes of treatments, approaches to monitoring the disease, and changing treatment based on patient and disease characteristics.
Expert Perspectives on Advances in the Management of Major Depressive Disorder
December 16th 2022Experts in psychiatry focus on treatment options for major depressive disorder (MDD). The discussion centers on data with newer mechanisms of action, new and emerging treatment options, and management of MDD in specific patient populations and how new treatments are aiming to fulfill unmet needs in MDD.
Advances in Targeted Therapy Selection in Rheumatoid Arthritis
December 7th 2022Rheumatology specialists discuss challenges in the management of rheumatoid arthritis (RA), and how the trial-and-error approach to treatment selection and continued use of ineffective treatments impacts quality of life in RA. The panel discusses tools available to guide treatment selection and how personalization of care can improve treatment outcomes.
Recent Approvals in Vaccination Against SARS-CoV-2 and the Omicron Subvariants
October 24th 2022Expert health professionals provide key insights on recently approved SARS-CoV-2 booster shots highlighting current recommendations and optimizing patient communication and education on vaccination options.
Expert Perspectives on Managing Polyvascular Disease and Coronary Artery Disease
April 29th 2022A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.
JAK inhibitors for the Management of Atopic Dermatitis (AD)
April 27th 2022Linda Stein Gold, MD; Raj J. Chovatiya, MD, PhD; Eric Simpson, MD, MCR; and Alexandra K. Golant, MD, share their approaches to optimizing the treatment of atopic dermatitis with a focus on the utilization of topical and oral JAK inhibitors.